# MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease

> **NCT04052191** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Honya Medical Inc** · enrollment: 40 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **BIOLOGICAL:** MCRcI® stem cells

## Key facts

- **NCT ID:** NCT04052191
- **Lead sponsor:** Honya Medical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04052191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04052191, "MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04052191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*